Senores Pharmaceuticals Limited - Laporan Laba Rugi (TTM)

Senores Pharmaceuticals Limited
IN ˙ NSEI
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Senores Pharmaceuticals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2022
03-31
2023
03-31
2024
03-31
2024
12-31
2025
03-31
2025
06-30
Revenue 142 353 2,145 3,865 3,982 4,558
Change (%) 149.38 507.07 80.16 3.04 14.46
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 81 128 1,089 1,714 1,874 2,074
Change (%) 58.46 750.73 57.41 9.38 10.68
% of Revenue 56.99 36.21 50.75 44.34 47.06 45.51
Gross Operating Profit 61 225 1,057 2,151 2,108 2,484
Change (%) 269.83 368.75 103.61 -2.00 17.82
% of Revenue 43.01 63.79 49.25 55.66 52.94 54.49
SG&A 29 52 363 648 636 700
Change (%) 78.94 601.64 78.56 -1.90 10.05
% of Revenue 20.41 14.64 16.93 16.78 15.97 15.35
R&D
Change (%)
% of Revenue
OpEx 129 244 1,829 3,091 3,254 3,726
Change (%) 89.14 648.44 68.97 5.26 14.52
% of Revenue 91.20 69.17 85.28 79.98 81.70 81.74
Operating Income 12 109 316 774 729 832
Change (%) 773.62 189.88 144.99 -5.80 14.23
% of Revenue 8.80 30.83 14.72 20.02 18.30 18.26
Interest Expense -5 -18 -85 -183 -204 -218
Change (%) 260.20 362.71 115.65 11.13 6.87
% of Revenue -3.60 -5.20 -3.96 -4.74 -5.11 -4.78
Net Income 10 84 314 567 586 676
Change (%) 750.96 272.94 80.17 3.34 15.37
% of Revenue 6.99 23.86 14.66 14.66 14.70 14.82

Source: Capital IQ

Other Listings
IN:544319
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista